Pallas Capital Advisors LLC Charles River Laboratories International, Inc. Transaction History
Pallas Capital Advisors LLC
- $2.31 Billion
- Q1 2024
A detailed history of Pallas Capital Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 10,938 shares of CRL stock, worth $2.2 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
10,938
Previous 5,643
93.83%
Holding current value
$2.2 Million
Previous $1.33 Million
122.11%
% of portfolio
0.13%
Previous 0.07%
Shares
11 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.04 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$422 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$378 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$305 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...